Oryzon Genomics SA (ORYZF)
3.31
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Oryzon Genomics Net Income (Annual) : -2.940M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -2.940M |
| December 31, 2024 | -3.870M |
| December 31, 2023 | -3.625M |
| December 31, 2022 | -4.447M |
| December 31, 2021 | -5.540M |
| December 31, 2020 | -3.875M |
| December 31, 2019 | -4.124M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.389M |
| December 31, 2017 | -5.862M |
| December 31, 2016 | -6.027M |
| December 31, 2015 | -1.100M |
| December 31, 2014 | 8.822M |
| December 31, 2013 | -2.866M |
| December 31, 2012 | -0.7813M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Pharma Mar SA | 84.63M |
| Grifols SA | 564.29M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alkermes Plc | 241.66M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |